Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.37 USD | +2.59% |
|
+5.18% | +10.70% |
| 06-30 | BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating | MT |
| 06-29 | Edwards Lifesciences Secures US FDA Approval for Ecliptis System | MT |
| Market Cap | 54.34B 47.48B 43.6B 40.66B 77.08B 5,173B 78.38B 525B 203B 2,537B 204B 200B 8,743B | P/E 2026 * |
33.7x | P/E 2027 * | 28.8x |
|---|---|---|---|---|---|
| Enterprise Value | 50.86B 44.44B 40.81B 38.05B 72.14B 4,842B 73.36B 491B 190B 2,375B 191B 187B 8,183B | EV / Sales 2026 * |
7.54x | EV / Sales 2027 * | 6.65x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +2.59% | ||
| 1 week | +5.18% | ||
| Current month | +4.32% | ||
| 1 month | +7.65% | ||
| 3 months | +16.43% | ||
| 6 months | +10.59% | ||
| Current year | +10.70% |
| 1 week | 89.69 |  | 94.47 |
| 1 month | 83.17 | | 94.47 |
| Current year | 74.66 | | 94.47 |
| 1 year | 72.3 | | 94.47 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Fiscal year | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 06-17 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 05-29 | Sell | Controller/Auditor | -568 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.59% | +5.18% | +22.53% | +0.04% | 54.34B | |
| +1.97% | +3.50% | +22.37% | +0.32% | 195B | |
| +5.87% | +6.59% | -21.20% | +24.59% | 151B | |
| +2.17% | +2.44% | -2.26% | -17.53% | 140B | |
| +4.83% | +2.13% | -56.44% | -16.55% | 67.09B | |
| -0.73% | +1.49% | -26.00% | -31.47% | 44.64B | |
| -2.02% | -3.56% | +8.31% | +8.68% | 36.91B | |
| +0.31% | +0.64% | +7.78% | +42.30% | 37.24B | |
| +1.09% | +0.96% | -13.87% | -19.29% | 29.82B | |
| +4.24% | +5.55% | -18.07% | -4.06% | 30.27B | |
| Average | +1.47% | +2.52% | -7.68% | -1.30% | 78.58B | |
| Weighted average by Cap. | +1.59% | +3.44% | -4.14% | +0.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.75B 5.9B 5.41B 5.05B 9.57B 642B 9.73B 65.19B 25.27B 315B 25.34B 24.79B 1,086B | 7.41B 6.48B 5.95B 5.55B 10.51B 705B 10.69B 71.59B 27.75B 346B 27.82B 27.22B 1,192B |
| Net income | 1.62B 1.42B 1.3B 1.22B 2.3B 155B 2.34B 15.69B 6.08B 75.85B 6.1B 5.97B 261B | 1.89B 1.65B 1.52B 1.42B 2.68B 180B 2.73B 18.27B 7.08B 88.31B 7.1B 6.95B 304B |
| Net Debt | -3.48B -3.04B -2.79B -2.61B -4.94B -332B -5.02B -33.64B -13.04B -163B -13.08B -12.79B -560B | -5.07B -4.43B -4.07B -3.8B -7.2B -483B -7.32B -49.01B -18.99B -237B -19.05B -18.63B -816B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $94.37 | +2.59% | 3,206,400 |
| 01/07/26 | $91.99 | +1.69% | 4,284,007 |
| 30/06/26 | $90.46 | -0.79% | 3,627,318 |
| 29/06/26 | $91.18 | +0.44% | 3,606,384 |
| 26/06/26 | $90.78 | +1.18% | 14,420,825 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
